Together these results extend the work of Baratz and colleagues [44] and define a therapeutic window of up to 12 h post mTBI to mitigate cognitive deficits by lowering TNF-α generation, as well as documenting the time course of TNF-α elevation. The gene discussed is TNF; the disease is Cognitive impairment.